Abbott announced today that it entered a first-of-its-kind agreement to integrate data from its Libre systems into Epic EHR ...

Abbott recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 CGM systems.

If you use Abbott’s FreeStyle Libre 2 and 3 CGM systems, this new FDA clearance ... and avoid any potential issues during the scan.

Meanwhile, Novo Nordisk struck deals with several telehealth companies to sell its GLP-1 drug semaglutide for obesity ...

Abbott Laboratories received FDA clearance for its newest continuous glucose monitor, the FreeStyle Libre 2. The product is one of many in a growing market for CGMs. Choosing the right software ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

Abbott has entered a first-of-its-kind agreement to integrate data from FreeStyle Libre CGM systems directly into Epic electronic health record systems in the United States, allowing clinicians to vie ...

April 29, 2025 /PRNewswire/ -- Abbott (ABT), the global leader in continuous glucose monitoring (CGM) biowearable technology ... outside US version of the FreeStyle Libre 14 day system.

Collaboration brings together FreeStyle Libre ® Systems, the world's leading continuous glucose monitoring technology (CGM) 1 with Epic, a healthcare software company, to streamline access to CGM data ...